CUE
Price
$0.64
Change
+$0.01 (+1.59%)
Updated
Jun 6 closing price
Capitalization
47.4M
93 days until earnings call
OCS
Price
$19.98
Change
+$0.42 (+2.15%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
1.04B
Interact to see
Advertisement

CUE vs OCS

Header iconCUE vs OCS Comparison
Open Charts CUE vs OCSBanner chart's image
Cue Biopharma
Price$0.64
Change+$0.01 (+1.59%)
Volume$132.23K
Capitalization47.4M
Oculis Holding AG
Price$19.98
Change+$0.42 (+2.15%)
Volume$4.29K
Capitalization1.04B
CUE vs OCS Comparison Chart
Loading...
CUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CUE vs. OCS commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CUE is a StrongBuy and OCS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (CUE: $0.64 vs. OCS: $19.92)
Brand notoriety: CUE and OCS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CUE: 80% vs. OCS: 118%
Market capitalization -- CUE: $47.4M vs. OCS: $1.04B
CUE [@Biotechnology] is valued at $47.4M. OCS’s [@Biotechnology] market capitalization is $1.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CUE’s FA Score shows that 0 FA rating(s) are green whileOCS’s FA Score has 0 green FA rating(s).

  • CUE’s FA Score: 0 green, 5 red.
  • OCS’s FA Score: 0 green, 5 red.
According to our system of comparison, OCS is a better buy in the long-term than CUE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CUE’s TA Score shows that 6 TA indicator(s) are bullish while OCS’s TA Score has 6 bullish TA indicator(s).

  • CUE’s TA Score: 6 bullish, 2 bearish.
  • OCS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, CUE is a better buy in the short-term than OCS.

Price Growth

CUE (@Biotechnology) experienced а +0.47% price change this week, while OCS (@Biotechnology) price change was +2.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

CUE is expected to report earnings on Sep 08, 2025.

OCS is expected to report earnings on Mar 11, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCS($1.04B) has a higher market cap than CUE($47.4M). OCS YTD gains are higher at: 14.824 vs. CUE (-41.193). CUE has higher annual earnings (EBITDA): -40.02M vs. OCS (-101.78M). OCS has more cash in the bank: 182M vs. CUE (32.4M). OCS has less debt than CUE: OCS (1.1M) vs CUE (9.51M). CUE has higher revenues than OCS: CUE (9.53M) vs OCS (0).
CUEOCSCUE / OCS
Capitalization47.4M1.04B5%
EBITDA-40.02M-101.78M39%
Gain YTD-41.19314.824-278%
P/E RatioN/A63.08-
Revenue9.53M0-
Total Cash32.4M182M18%
Total Debt9.51M1.1M862%
FUNDAMENTALS RATINGS
CUE: Fundamental Ratings
CUE
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CUEOCS
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 2 days ago
33%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 2 days ago
53%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 2 days ago
50%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
55%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 11 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 5 days ago
63%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 2 days ago
38%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
CUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EUDA3.440.09
+2.69%
EUDA Health Holdings Limited
TATT27.200.70
+2.64%
TAT Technologies Ltd
IMKTA60.970.50
+0.83%
Ingles Markets
GGB2.970.01
+0.34%
Gerdau SA
CRH92.54-0.26
-0.28%
CRH Public Limited

OCS and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with SNSE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
+1.93%
SNSE - OCS
34%
Loosely correlated
+2.53%
CUE - OCS
33%
Loosely correlated
+1.45%
PRAX - OCS
29%
Poorly correlated
+1.91%
CGEN - OCS
28%
Poorly correlated
+0.58%
GRI - OCS
27%
Poorly correlated
-4.14%
More